Amrutanjan Health Care share news, announcements and annual reports
NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap
Amrutanjan Health Care Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last close ₹493.20up ₹0.20 (0.04%)BSE ₹493.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹493.00.
29 Oct: open ₹490.10, high ₹500.00, low ₹490.10
52-week range of traded prices to 29 Oct 2026
₹476.50Low, 16 Sep 2026₹760.15High, 29 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,426 Cr1,245th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.42
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 21.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 18.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,00054.0% delivered
Amrutanjan Health Care disputes and clarifications
21 filed, newest first.
Aug 2026
1 Aug · Legal
Mar 2026
18 Mar · Legal
Oct 2025
18 Oct · Legal
Mar 2025
3 Mar · Legal
3 Mar · Legal
Aug 2024
29 Aug · Legal
Exchange has sought clarification from Amrutanjan Health Care Limited with respect to announcement dated 13-Aug-2024, regarding " Amrutanjan Health Care Limited has informed the Exchange regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authorityThe response of the Company is awaited.
Jun 2023
16 Jun · Legal
Exchange has sought clarification from Amrutanjan Health Care Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Oct 2021
15 Oct · Legal
The exchange asked on 13 Oct 2021
May 2021
27 May · Legal
Exchange has sought clarification from Amrutanjan Health Care Limited with respect to announcement dated 27-May-2021, regarding its outcome of Board meeting held on May 27, 2021. On basis of above the Company is required to provide confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018. The response of the Company is awaited.
Jan 2021
5 Jan · Legal
The exchange asked on 4 Jan 2021
Jul 2020
31 Jul · Legal
The exchange asked on 30 Jul 2020
Dec 2018
24 Dec · Legal
The exchange asked on 21 Dec 2018
Aug 2018
27 Aug · Legal
The exchange asked on 24 Aug 2018
Nov 2017
10 Nov · Legal
Exchange has sought clarification from Amrutanjan Health Care Limited with respect to announcement dated 09-Nov-2017, regarding "Amrutanjan Health Care Limited has informed the Exchange regarding Appointment of Mr. N Swaminathan as Chief Financial Officer of the company w.e.f. November 09, 2017 ". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.
Oct 2014
21 Oct · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in Amrutanjan Health Care Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Amrutanjan Health Care Limited has vide its letter inter-alia stated," We wish to keep you informed that no significant reason need to be attached in this regard." (Source MSE)
Sep 2014
8 Sep · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in Amrutanjan Health Care Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Amrutanjan Health Care Limited has vide its letter inter-alia stated," We wish to keep you inform that no significant reason need to be attached in this regard excepting for the Company's fundamental strength and financial performance." (Source MSE)
Oct 2012